Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safety.

about

Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project.Basal cell naevus syndrome: an update on genetics and treatment.Role of Vismodegib in the Management of Advanced Periocular Basal Cell Carcinoma.

P2860

Q37653445-A3472F6C-12F2-4A3D-A673-BECFE7EA2EF8 Q38593322-74DBC20F-A3E9-43B6-A09D-B6D184105B06 Q38842917-CDBCCE4F-C24D-442D-AD94-B232E490F73E

P2860

Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safety.

Item

http://www.wikidata.org/entity/Q38231365

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cholestatic hepatic injury ass ...... d review of vismodegib safety.

@en

type

Item

label

Cholestatic hepatic injury ass ...... d review of vismodegib safety.

@en

prefLabel

Cholestatic hepatic injury ass ...... d review of vismodegib safety.

@en

P1476

Cholestatic hepatic injury ass ...... d review of vismodegib safety.

@en

P2093

Mark M Ash

http://www.w3.org/2001/XMLSchema#string

Puneet S Jolly

http://www.w3.org/2001/XMLSchema#string

P2860

Nevoid basal cell carcinoma syndrome (Gorlin syndrome)

Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.

Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients.

Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer.

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Drug-induced hepatotoxicity.

The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine

P304

370-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJD.12543

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25039741

http://www.w3.org/2001/XMLSchema#string

Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safety.

about

P2860

P2860

Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safety.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698